Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes

5,148 patients hospitalized with an acute coronary syndrome (ACS) who survived to discharge (1,716 cases who died within 6 months, 3,432 controls who survived to 6 months, matched for ACS diagnosis, age, and GRACE risk score)

Guideline-advocated therapies including evidence-based medications (statins, clopidogrel) and coronary interventions (angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery)

Non-use or incomplete application of each therapy

Death within 6 monthshard clinical